Publications

Find coverage of the latest original articles on Lupus, focusing on those with data on therapeutic interventions and those that have clinical impact.

This activity is supported by an educational grant from AstraZeneca.

Anifrolumab, Mycophenolate mofetil, Sm-Tregs, CAR T-Cell, CV Risk factors,

February 2023

Lupus. 2023. doi: 10.1177/09612033231153791

Ambispective cohort study concludes that, in addition to disease classification, the EULAR/ACR SLE criteria may have value in predicting prognosis.